JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Complications and Carcinogenic Effects of Mustard Gas - a Systematic Review and Meta-Analysis in Iran
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Complications and Carcinogenic Effects of Mustard Gas - a Systematic Review and Meta-Analysis in Iran
Panahi, Yunes; Gholami, Nasrin; Ghojazadeh, Morteza; Moslemi, Farnaz; Naghavi-Behzad, Mohammad; Azami-Aghdash, Saber; Ghaffari, Alireza; Piri, Reza;
  PDF(new window)
 Abstract
Background: Catastrophic effects of mustard gas as a chemical warfare agent have always been a major problem for those exposed to this agent. In this meta-analysis it was tried to evaluate carcinogenesis, ocular, cutaneous and respiratory complications of mustard gas exposure among Iranians who had been exposed to this agent during the Iran-Iraq war. Materials and Methods: In this meta-analysis, the required data were collected using keywords "mustard gas", "sulfur mustard", "cancer", "neoplasm", "respiratory complications", "ocular complications", "lung disease", "chronic complication", "eye", "skin", "cutaneous complication", "carcinogenesis" and their combination with keywords "Iran", "Iranian", "prevalence", "mortality" and their Farsi equivalent terms from the databases of SID, Iranmedex, Magiran, Pubmed, Science Direct, Google Search engine, Gray Literature and Reference of References. To determine the prevalence of each complication and perform meta-analysis, CMA: 2 (Comprehensive Meta-Analysis) software with a randomized model was used. Results: Of the 542 articles found, 7 national articles, consistent with the aims of this study were selected. Meta-analysis of seven papers revealed that cancer risk, especially cancer of the respiratory system was elevated, so that the relative risk (RR) of cancer role of mustard gas was inconsistent from 2/1 to 4 in this survey. Also prevalence of delayed skin disorders due to sulfur mustard was 94.6%, pulmonary complications 94.5% and ocular complications 89.9%. The incidence of various cancers in victims exposed to mustard gas was 1.7% worldwide where the rate was 2.2% in Iranian victims of the Iraq-Iran war. Conclusions: Based on present study the prevalence of delayed mustard gas related cutaneous, pulmonary and ocular complications is above 90% and risk of carcinogenesis is higher in comparison to worldwide statistics. This may suggest need for long-term and persistent follow-up and rehabilitation procedures for populations exposed to this agent.
 Keywords
Mustard gas;carcinogenic;neoplasm;complication;Iran;meta-analysis;
 Language
English
 Cited by
1.
A review on symptoms, treatments protocols, and proteomic profile in sulfur mustard-exposed victims, Journal of Cellular Biochemistry, 2017, 119, 1, 197  crossref(new windwow)
2.
TGF-β and Th17 cells related injuries in patients with sulfur mustard exposure, Journal of Cellular Physiology, 2017, 233, 4, 3037  crossref(new windwow)
3.
Novel treatment opportunities for sulfur mustard-related cancers: genetic and epigenetic perspectives, Archives of Toxicology, 2017, 91, 12, 3717  crossref(new windwow)
 References
1.
Abbas F (1984). Report of the specialists appointed by the Secretary-General of the United Nations to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. Archives belges= Belgisch archief, 302.

2.
Agin K, Broumand G (2004). Epidemiological relationship with late complications of sulfur mustard gas on 500 Iranian chemically injured after 15 years. J Army Univ Med Sci I.R.Iran, 2, 269-73.

3.
Amirnia M, Babaie-ghazani A, Fakhrjou A, et al (2014). Immunohistochemical study of cyclooxygenase-2 in skin tumors. J Dermatolog Treatment, 25, 380-7. crossref(new window)

4.
Balali-Mood M, Hefazi M, Mahmoudi M, et al (2005). Longterm complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundamental & Clinical Pharmacology, 19, 713-21. crossref(new window)

5.
Barar J, Omidi Y (2012). Translational approaches towards cancer gene therapy: hurdles and hopes. BioImpacts: BI, 2, 127.

6.
Bhavana SM, Lakshmi CR (2014). Oral Oncoprevention by Phytochemicals-A Systematic Review Disclosing the Therapeutic Dilemma. Advanced Pharmaceutical Bulletin, 4, 413.

7.
Chatterjee D, Mukherjee S, Smith MG, et al (2003). Signal transduction events in lung injury induced by 2 chloroethyl ethyl sulfide, a mustard analog. J Biochemical and Molecular Toxicol, 17, 114-21. crossref(new window)

8.
Doi M, Hattori N, Yokoyama A, et al (2011). Effect of mustard gas exposure on incidence of lung cancer: a longitudinal study. Am J Epidemiol, 173, 659-66. crossref(new window)

9.
Easton D, Peto J, Doll R (1988). Cancers of the respiratory tract in mustard gas workers. Br J Industrial Med, 45, 652-9.

10.
Eisenmenger W, Drasch G, Clarmann Mv, et al (1991). Clinical and morphological findings on mustard gas [bis (2-chloroethyl) sulfide] poisoning. J Forensic Sci, 1688-98.

11.
Emad A, Rezaian GR (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure analysis of 197 cases. CHEST J, 112, 734-8. crossref(new window)

12.
Emadi S, Mortazavi M, Mortazavi H (2008). Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: A long-term investigation. Archives of Dermatology, 144, 1059-61.

13.
Fraumeni Jr J (1975). Respiratory carcinogenesis: an epidemiologic appraisal. J National Cancer Institute, 55, 1039. crossref(new window)

14.
Geraci MJ (2008). Mustard gas: imminent danger or eminent threat? Ann Pharmacotherapy, 42, 237-46. crossref(new window)

15.
Ghabili K, Agutter PS, Ghanei M, et al (2010). Mustard gas toxicity: the acute and chronic pathological effects. J Applied Toxicol, 30, 627-43. crossref(new window)

16.
Ghabili K, Shoja MM, Golzari SE, et al (2013). Mustard gas keratitis: a common misnomer. Cornea, 32, 382-3.

17.
Ghaneei M, Alavian S, Nasiri M, et al (2007). Alanin aminotransferase activity in veterans exposed to sulfur mustard. Iranian Journal of Endocrinology and Metabolism (IJEM).

18.
Ghanei M, Vosoghi AA (2002). An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environmental health perspectives, 110, 519. crossref(new window)

19.
Gharemohammadlou R, Emad A (2013). Evaluating Installation of Local Steroids in Lung Volumes and Airway Resistance in Bronchiectasis Due to Mustard. Med J Tabriz University Med Sci Health Serv, 35, 72-7

20.
GhasemiBroumand M, Amiri Z (2008). Layed ocular complications of mustard gas in chemical injured 500 people. J Rehab, 8, 67-74.

21.
GhasemiBroumand M, Aslani J, Emadi N, et al (2006). Frequency of late ocular, dermatological and respiratory complications due to exposure of mustard gas in Sardasht 2004. Pejouhandeh, 11, 9-15.

22.
GhasemiBroumand M, Karami R, Pourfarzam S, et al (2007). Late complications of ocular, respiratory, dermatological and psychiatric (PTSD) caused by chemical agents. Daneshvar Med, 14, 81-92.

23.
Gilasi H, Holakouie Naieni K, Zafarghandi M, et al (2006). Relationship between mustard gas and cancer in Iranian soldiers of imposed war in Isfahan Province: A Pilot Study. J School of Public Health and Institute of Public Health Research, 4, 15-23.

24.
Heston W (1953). Occurrence of tumors in mice injected subcutaneously with sulfur mustard and nitrogen mustard. J National Cancer Institute, 14, 131-40.

25.
Jabbari H, Alikhah H, Sahebkaram Alamdari N, et al (2012). Developing the Use of Quality Indicators in Sterilization Practices. Iranian J Public Health, 41, 64-9.

26.
Karalliedde L, Wheeler H, Maclehose R, et al (2000). Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health, 114, 238-48. crossref(new window)

27.
Kehe K, Szinicz L (2005). Medical aspects of sulphur mustard poisoning. Toxicology, 214, 198-209. crossref(new window)

28.
Le H, Knudsen S (2006). Exposure to a first world war blistering agent. Emergency Medicine Journal, 23, 296-9. crossref(new window)

29.
Manning K, Skegg D, Stell P, et al (1981). Cancer of the larynx and other occupational hazards of mustard gas workers. Clinical Otolaryngology & Allied Sciences, 6, 165-70. crossref(new window)

30.
Marzban S (1986). Treatment of Iran in mustard gas injuries. University lahadoflrnn, 1, 1-25.

31.
McClintock SD, Till GO, Smith MG, et al (2002). Protection from half mustard gas induced acute lung injury in the rat. J Applied Toxicology, 22, 257-62. crossref(new window)

32.
Mirsadraee M, Attaran D, Boskabady M, et al (2005). Airway hyperresponsiveness to methacholine in chemical warfare victims. Respiration, 72, 523-8. crossref(new window)

33.
Mortazavi H, Baharvand M, Mehdipour M (2014). Oral potentially malignant disorders: an overview of more than 20 entities. J Dental Res, Dental Clinics, Dental Prospects, 8, 6.

34.
Najafi A, Masoudi-Nejad A, Imani Fooladi AA, et al (2014). Microarray gene expression analysis of the human airway in patients exposed to sulfur mustard. J Receptors and Signal Transduction, 34, 283-9. crossref(new window)

35.
Namazi S, Niknahad H, Razmkhah H (2009). Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans. J Med Toxicol, 5, 191-5. crossref(new window)

36.
Naraghi ZS, Mansouri P, Mortazavi M (2005). A clinicopathological study on acute cutaneous lesions induced by sulfur mustard gas (yperite). European Journal of Dermatology, 15, 140-5.

37.
Nishimoto Y, Yamakido M, Shigenobu T, et al (1983). Long-term observation of poison gas workers with special reference to respiratory cancers. J UOEH, 5, 89-94.

38.
Norman JE (1975). Lung cancer mortality in World War I veterans with mustard-gas injury: 1919-1965. J National Cancer Institute, 54, 311-7. crossref(new window)

39.
Program NT (2011). NTP 12th Report on Carcinogens. Report on carcinogens: carcinogen profiles/US Dept. of Health and Human Services, Public Health Service, National Toxicology Program, 12, 3.

40.
Ray R, Keyser B, Benton B, et al (2008). Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses*. Drug and chemical toxicology, 31, 137-48. crossref(new window)

41.
Riazi A, Jadidi K, Naderi M, et al (2004). Refractive errors in victims of chemical mustard as a delayed complication. J Mil Med, 6, 13-8.

42.
Safarinejad M (2001). Testicular effect of mustard gas. Urology, 58, 90-4. crossref(new window)

43.
Saleh P, Bastani P, Piri R, et al (2013). Antimicrobial prophylaxis for surgical site infections in surgical wards in northwest Iran. Life Sci J, 10, 1977-81.

44.
Sasser L, Miller R, Kalkwarf D, et al (1996). Subchronic toxicity evaluation of sulfur mustard in rats. Journal of Applied Toxicology, 16, 5-13. crossref(new window)

45.
Security SS-cotBHSttMoH (2011). Report on mustard gas experiments (Glasgow and London). Homeopathy, 100, 27-35. crossref(new window)

46.
Shigenobu T (1980). Occupational cancer of the lungs--cancer of the respiratory tract among workers manufacturing poisonous gases. Nihon Kyobu Shikkan Gakkai zasshi, 18, 880.

47.
Sokouti M, Golzari SE, Pezeshkian M, et al (2013). The role of esophagogastric anastomotic technique in decreasingbenign stricture formation in the surgery of esophageal carcinoma. J Cardiovascular Thoracic Res, 5, 11.

48.
Soroush MR, Ghanei M, Assari S, et al (2009). Urogenital history in veterans exposed to high-dose sulfur mustard: a preliminary study of self-reported data. Urology journal, 6, 114-9.

49.
Stuart JA, Ursano RJ, Fullerton CS, et al (2003). Belief in exposure to terrorist agents: reported exposure to nerve or mustard gas by Gulf War veterans. The Journal of nervous and mental disease, 191, 431-6. crossref(new window)

50.
Tokuoka S, Hayashi Y, Inai K, et al (1986). Early cancer and related lesions in the bronchial epithelium in former workers of mustard gas factory. Pathology International, 36, 533-42. crossref(new window)

51.
Wada S, Miyanishi M, Nishimoto Y, et al (1968). Mustard gas as a cause of respiratory neoplasia in man. The Lancet, 291, 1161-3. crossref(new window)

52.
Zafarghandi MR, Soroush MR, Mahmoodi M, et al (2013). Incidence of cancer in Iranian sulfur mustard exposed veterans: a long-term follow-up cohort study. Cancer Causes & Control, 24, 99-105. crossref(new window)

53.
Zandieh T, Marzban S, Hassiri G, et al (1990). Evaluation of cell-mediated immunity in mustard gas injuries. Medical Journal of The Islamic Republic of Iran (MJIRI), 4, 257-60.

54.
Zarchi K, Akbar A, Naieni KH (2004). Long-term pulmonary complications in combatants exposed to mustard gas: a historical cohort study. International Journal of Epidemiology, 33, 579-81. crossref(new window)

55.
Zojaji R, Balali-Mood M, Mirzadeh M, et al (2009). Delayed head and neck complications of sulphur mustard poisoning in Iranian veterans. The Journal of Laryngology & Otology, 123, 1150-4. crossref(new window)